Draganfly Earns New Record Fourth Quarter Sales and New Record Annual Sales
04 avr. 2022 08h40 HE
|
Draganfly Inc
Los Angeles, CA., April 04, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solution developer...
Incysus Therapeutics to Present at LifeSci Partners Summer Symposium
03 août 2020 07h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell...
Incysus Therapeutics Initiates Enrollment in Phase 1 Study of a Genetically Modified Gamma-Delta (γδ) T Cell Immunotherapy in Patients with Newly Diagnosed Glioblastoma
27 févr. 2020 07h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
National Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement Award
18 mai 2019 17h45 HE
|
National Lipid Association
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown...
Incysus Therapeutics Announces FDA Approval of IND Application for a Novel Gamma-Delta (γδ) T Cell Therapy for Treatment of Patients With Newly-Diagnosed Glioblastoma
01 avr. 2019 08h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Gamma-Delta T Cell Immunotherapy Pioneer, Lawrence Lamb, PhD, to Join Incysus Therapeutics as Chief Scientific Officer
03 janv. 2019 14h30 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
University of Alabama Professor Elected to the American College of Prosthodontists Board of Directors
28 déc. 2017 11h23 HE
|
American College of Prosthodontists
Chicago, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daniel A. Givan, DMD, PhD, FACP, was elected as Secretary for the Board of Directors of the American College of Prosthodontists (ACP), the national...
Blazing a new trail: Former UAB running back helps lead football resurgence
22 mai 2017 13h32 HE
|
Juke Slot
Birmingham, Alabama, May 22, 2017 (GLOBE NEWSWIRE) -- When the University of Alabama at Birmingham sidelined its football program after the 2014 season because of a lack of funding, Jegil Dugger...
The University of Alabama at Birmingham Selects Apogee to Boost Network Speeds and Wi-Fi for Five Residential Halls
12 août 2014 10h10 HE
|
Apogee
AUSTIN, TX--(Marketwired - Aug 12, 2014) - Apogee, higher education's largest residential network (ResNet) provider, announced today that the company has been selected by the University of Alabama...